Study concept and design: Margolis, Kerby, Maciosek, O’Connor.
Acquisition of data: Margolis, Bergdall, Groen, Kadrmas, Kerby, Klotzle, Michels, O’Connor, Pritchard, Sekenski, Trower.
Analysis and interpretation of data: Margolis, Asche, Bergdall, Dehmer, Maciosek, O’Connor, Sperl-Hillen.
Drafting of the manuscript: Margolis, Asche, Bergdall, Dehmer, Kadrmas, O’Connor, Sperl-Hillen, Trower.
Critical revision of the manuscript for important intellectual content: Asche, Bergdall, Dehmer, Groen, Kerby, Klotzle, Maciosek, Michels, O’Connor, Pritchard, Sekenski, Sperl-Hillen.
Statistical analysis: Asche, Dehmer, Trower.
Obtained funding: Margolis, Kerby, Maciosek.
Administrative, technical, or material support: Margolis, Bergdall, Groen, Kerby, Klotzle, Maciosek.
Study supervision: Margolis, Bergdall, Kerby, Maciosek.
Conflict of Interest Disclosures: The authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Drs Margolis, Dehmer, Maciosek, O’Connor, and Sperl-Hillen, Mr Asche, and Mss Bergdall, Kerby, Pritchard, Sekenski, and Trower reported receiving grant support administered through HealthPartners Institute for Education and Research for work on HyperLink. Dr O’Connor also reported receiving payment for lectures from the State of Montana Diabetes Program, the Centers for Disease Control and Prevention, and Peking University; has a patent pending for diabetes clinical decision support; and has received reimbursement for travel from the American Diabetes Association, the International Diabetes Federation, the National Institutes of Health, and the International Conference on Diabetes and Depression. Dr Sperl-Hillen also reported being listed as an inventor on US patent No. 8,388,342 B2 issued in 2013 entitled “Disease Treatment Simulation.” She is eligible to receive revenue in the future per HealthPartners Institute for Education and Research intellectual property policy. To date, she has received no payment for this role. HealthPartners Institute for Education and Research has recently entered into a royalty-bearing license agreement with a third party to commercialize the simulated learning technology for the purpose of broader dissemination. Dr Sperl-Hillen will serve as a nonpaid director on the board of directors for that licensee. No other author reported disclosures.
Funding/Support: This study is supported by grant R01HL090965 from the National Heart, Lung, and Blood Institute.
Role of the Sponsor: The National Heart, Lung, and Blood Institute had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.